Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2025-12-25 @ 2:47 AM
NCT ID:
NCT01836133
Eligibility Criteria:
Inclusion Criteria:
* Adult participants, \>/= 18 years of age
* Histologically or cytologically confirmed, locally advanced (Stage IIIb) or metastatic (Stage IV) adenocarcinoma non-small cell lung cancer
* Eastern Cooperative Oncology Group (ECOG) performance status 0-1
* Adequate hematologic, renal and liver function
* Participant initiating treatment with Tarceva according to the Summary of Product Characteristics
Exclusion Criteria:
* Any contraindications to treatment with Tarceva according to the Summary of Product Characteristics and local label
* Any other malignancies within the previous 5 years, except for in situ carcinoma of the cervix and basal and squamous cell carcinoma of the skin
* Previous systemic anti-cancer treatment with HER1/EGFR inhibitor
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01836133
Study Brief:
Protocol Section:
NCT01836133